Takamichi Yokoe

8PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersClinical midwiferyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 11, 2026
Highly cosmetic and safe breast-conserving surgery using a wave-like periareolar incision with sub-nipple and extensive subcutaneous dissection: a retrospective cohort study.

|Apr 26, 2025
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.

Ayako Nakashoji, Atrayee Bhattacharya, Hiroki Ozawa

|Feb 11, 2025
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022.

Takamichi Yokoe, Tetsuhiro Yoshinami, Kazuki Nozawa

|Apr 02, 2021
Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast.

Satoi Nagasawa, Yuta Kuze, Ichiro Maeda

|Jan 03, 2021
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B).

Takamichi Yokoe, Sasagu Kurozumi, Kazuki Nozawa

|May 26, 2020
Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score-matched analysis of SEER data.

Rurina Watanuki, Tetsu Hayashida, Takamichi Yokoe

Pageof 2

Frequent Collaborators

1 joint publications

Rurina Watanuki

1 joint publications

Ichiro Maeda

1 joint publications

Manabu Kubota

1 joint publications

Yutaka Suzuki